Verve Therapeutics Revenue

In the year 2022, Epibiotech had annual revenue of 449.62M KRW with 15.93% growth.

Revenue

449.62M

Revenue Growth

+15.93%

P/S Ratio

55.87

Revenue / Employee

n/a

Employees

n/a

Market Cap

25.12B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	449.62M	61.77M	15.93%
Dec 31, 2021	387.85M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition